Suchergebnisse - "Debeljak, Jerneja"

PubPharm (3)

1

Immunophenotypes of anti-SARS-CoV-2 responses associated with fatal COVID-19

enthalten in: ERJ open research | 2022

von Šelb, J. | Bitežnik, B. | Bidovec Stojković, U. | +28

2

Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination

enthalten in: Future oncology (London, England) | 2022

von Janzic, U. | Bidovec-Stojkovic, U. | Mohorcic, K. | +9

3

Adequate Immunogenicity And Low Rate of Severe Adverse Events After SARS-CoV-2 mRNA-Based Vaccination In Patients With Solid Malignancies On Active Treatment Starts To Decline 3 Months After Complete Primary Course of Vaccination

enthalten in: ResearchSquare.com | 2022

von Janzic, U. | Bidovec-Stojkovic, U. | Mohorcic, K. | +9

1
[1]